Who are Mg Oxide's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Pizensy, Miralax, Cephulac, Milk of Magnesia, Polyethelene Glycol, Gatorade/Miralax.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/mg-oxide.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Mg Oxide — Competitive Intelligence Brief

Mg Oxide (Mg Oxide) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic laxative; magnesium supplement. Area: Gastroenterology; Nutritional supplementation.

marketed Osmotic laxative; magnesium supplement Gastroenterology; Nutritional supplementation Small molecule Live · refreshed every 30 min

Target snapshot

Mg Oxide (Mg Oxide) — Shiraz University of Medical Sciences. Magnesium oxide acts as an osmotic laxative and magnesium supplement by drawing water into the intestinal lumen to promote bowel movements and increase serum magnesium levels.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Mg Oxide TARGET	Mg Oxide	Shiraz University of Medical Sciences	marketed	Osmotic laxative; magnesium supplement
Pizensy	LACTITOL	Braintree Labs	marketed	Osmotic Laxative		2020-01-01
Miralax	Macrogol	Braintree	marketed	Osmotic Laxative [EPC]		1984-01-01
Cephulac	LACTULOSE	Sanwa Kagaku Kenkyusho Co., Ltd.	marketed	Osmotic Laxative [EPC]		1976-01-01
Milk of Magnesia	magnesium hydroxide	Generic (multiple manufacturers)	marketed	Osmotic laxative, Antacid	Gastric acid (direct neutralization) + osmotic effect in intestine	1880-01-01
Polyethelene Glycol	Polyethelene Glycol	St. Joseph's Healthcare Hamilton	marketed	Osmotic laxative
Gatorade/Miralax	Gatorade/Miralax	Gastroenterology Services, Ltd.	marketed	Osmotic laxative

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2032-03-09 — Miralax · 10780112 · US
2032-03-09 — Miralax · 11529368 · US
2032-03-09 — Miralax · 10792306 · US
2032-03-25 — Miralax · 10646512 · US
2032-08-11 — Miralax · 9592252 · US
2033-09-10 — Miralax · 9326969 · US
2033-09-10 — Miralax · 9707297 · US
2033-09-10 — Miralax · 8999313 · US
2033-09-10 — Miralax · 10918723 · US
2033-09-10 — Miralax · 10016504 · US

Sponsor landscape (Osmotic laxative; magnesium supplement class)

Shiraz University of Medical Sciences · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Mg Oxide — Competitive Intelligence Brief. https://druglandscape.com/ci/mg-oxide. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab